SCHEMBL25350511

SCHEMBL25350511

C[C@@H]1CN(c2cccc(C=O)c2)C[C@H](C)N1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UNG P13051 1/20 0.41
FAAH O00519 3/20 0.38
OPRM1 P35372 1/20 0.38
NOTUM Q6P988 3/20 0.37
ALDH1A1 P00352 3/20 0.37
TRIM24 O15164 1/20 0.36
TRIM33 Q9UPN9 1/20 0.36
FGFR1 P11362 1/20 0.35
PRMT1 Q99873 1/20 0.35
POLB P06746 1/20 0.35
SLC6A7 Q99884 1/20 0.35
ALOX5 P09917 1/20 0.35
HTR7 P34969 1/20 0.34
SRC P12931 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30409181 0.82 GPR119 (0.43)
SCHEMBL30409365 0.82 GPR119 (0.43)
SCHEMBL24215992 0.82 GPR119 (0.43)
SCHEMBL15861781 0.77 ALDH1A1 (0.44) UNGNOTUMALDH1A1TRIM24TRIM33
SCHEMBL1893248 0.77 HSD17B10 (0.44) ALDH1A1FGFR1KDM4EMEN1GAA
SCHEMBL12661593 0.77 HSD17B10 (0.44) ALDH1A1FGFR1KDM4EMEN1GAA
SCHEMBL2558065 0.76 UNG (0.41) UNGNOTUMALDH1A1TRIM24TRIM33
SCHEMBL25348513 0.75 CYP2C19 (0.41) FAAHOPRM1NOTUMALDH1A1ALOX5
SCHEMBL30286268 0.74 ALDH1A1 (0.44) UNGALDH1A1TRIM24TRIM33FGFR1
SCHEMBL28994726 0.74 ALDH1A1 (0.44) UNGALDH1A1TRIM24TRIM33FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 UNG 2240/4885FAAH 2415/4885OPRM1 3698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.